• Home
• Reports
• Companies

• Partnering Search
• Profiling
• PL Intelligence

• Out-licensing
• In-licensing
• Services

• Deals review
• Industry news
• Press releases

• Events
• Articles
• Newsletter

News of the day

PR Newswire search

Most viewed

Cervical Cancer Charity Welcomes Department of Health's Announcement About HPV Vaccine

Diabetes Online Health Guide Released on NHS Choices

Online NHS Health Guides for Long-Term Conditions Released on NHS Choices

Risk Management: Best Practices for Medical Device Profitability

Teva Welcomes Pharmacy White Paper

Browse by category

• Acquisitions, Mergers and Takeovers
• Animals/Pets
• Asian Related News
• Awards
• Black-oriented news
• Broadcast Feed Announcement
• Children Related News
• Clinical Trials/Medical Discoveries
• Conference Call Announcements
• Conservation/Recycling
• Contracts
• Corporate Social Responsibility
• Dividends
• Domestic Policy
• Earnings
• Earnings Projections or Forecasts
• Economic News, Trends, Analysis
• European Government
• FDA Approval
• Federal and State Legislation
• Federal Executive Branch, Agency News
• Financial Agreements
• Foreign Policy
• Handicapped/Disabled
• Hispanic Oriented News
• Investment Opinions
• Joint Ventures
• Labor News
• Legal Issues
• Lesbian/Gay/Bisexual
• Licensing/Marketing Agreements
• Media Advisory/Invitation
• MultiVu Audio
• New Products/Services
• Not for profit
• Offerings
• OTC/Small Cap IRW
• Patent Law
• Personnel Announcements
• Political Campaigns
• Product Recalls
• Public Safety
• Real Estate Transactions
• Religion
• Restructurings/Recapitalizations
• Sales Reports
• Senior Citizens
• Surveys, Polls and Research
• Trade Policy
• Trade Shows
• Venture Capital
• Veterans
• Women Related News

More recent news

Register Now For HBA Global Expo & Conference
2nd July 2009 NEW YORK, July 2 /PRNewswire/ -- WHY: HBA Global Expo is the leading product development event for the cosmetics, fragrance, personal care and wellness industries. For three days the entire...

Latest Guidance Issued by BTS/SIGN Supports use of Single Inhaler for Maintenance and Relief in Asthmatic Patients
2nd July 2009 LONDON, July 2 /PRNewswire/ -- Updated guidelines issued this week by the British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network (SIGN) include the use...

Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment
2nd July 2009 NEW BRUNSWICK, New Jersey and DUBLIN, July 2 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) and Elan Corporation plc (NYSE: ELN) today announced a definitive agreement whereby Johnson &...

FDA Approves Multaq(R) for Patients With Atrial Fibrillation or Atrial Flutter
2nd July 2009 PARIS, July 2 /PRNewswire/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets....

New Review on PROSTVAC(TM) Published by Key Investigators From NCI
1st July 2009 KVISTGAARD, Denmark, July 1 /PRNewswire/ -- A just published Review in the publication "Expert Opinion on Investigational Drugs", Volume 18, Issue 7 2009, confirms the previous published information...

LAP-BAND(TM) is First Obesity Intervention Device in Europe Indicated for Weight Loss That Improves or Leads to Remission of Type 2 Diabetes
1st July 2009 LONDON, July 1 /PRNewswire/ -- Allergan's LAP-BAND(TM) AP System for obesity intervention has become the first device to receive official European approval for weight loss that leads to improvement...

New York City's World Product Centre Announces Initial Charter Partners
1st July 2009 NEW YORK, July 1 /PRNewswire/ -- World Product Centre (WPC) today announced that Dublin, Ohio-based Cardinal Health -- one of the world's largest healthcare suppliers -- is among the first 11...

Eisai and Pfizer Decide not to Appeal NICE Decision and Call for an Expedited Review of Guidance for Alzheimer's Disease
1st July 2009 LONDON, July 1 /PRNewswire/ -- On June 11, the National Institute for Health and Clinical Excellence (NICE) announced that, following consultation with stakeholders on the economic model that...

Merck Serono Launches "Global Fertility Academy" to Provide Education and Training for the Treatment of Infertility
1st July 2009 GENEVA, Switzerland, July 1 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the launch of the Global Fertility Academy, the first global professional...

Frost & Sullivan European Gastroenterology Technology Implementation of the Year Award Bestowed on Crospon
1st July 2009 LONDON, July 1 /PRNewswire/ -- The Frost & Sullivan "2009 European Gastroenterology Technology Implementation of the Year Award," is presented to Ireland-based Crospon for successfully using the...

Gerresheimer Sells Technical Plastics Business
1st July 2009 DUSSELDORF, Germany, July 1 /PRNewswire/ -- Gerresheimer AG, a leading manu

Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America
30th June 2009 SAO PAULO, June 30 /PRNewswire/ -- A total success. That sums up the Health ingredients (Hi) South America Summit, held for the first time on June 15-16, 2009 at Sao Paulo's Novotel Centre Norte. The...

/C O R R E C T I O N -- Enigma Diagnostics Limited/
30th June 2009 PORTON DOWN, England, June 30 /PRNewswire/ -- In the news release, "Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UK's Veterinary Laboratories Agency" issued on 30 Jun...

Simbionix Signs Agreement With the European Association for Endoscopic Surgery
30th June 2009 PRAGUE - Prague Convention Center, June 30 /PRNewswire/ -- Simbionix and the European Association for Endoscopic Surgery (EAES) have signed an agreement to collaborate on the development of training...

Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UK's Veterinary Laboratories Agency
30th June 2009 PORTON DOWN, England, June 30 /PRNewswire/ -- Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today successful independent testing for bovine...

Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, a Novel Product Candidate for the Treatment of Respiratory Diseases
30th June 2009 SAN DIEGO, June 30 /PRNewswire/ -- Amira Pharmaceuticals, Inc. announced today initial positive data from a Phase 1 clinical study of AM211, the company's oral selective antagonist of the DP2 (also...

Huge Potential Returns for Healthcare Innovators
30th June 2009 LONDON, June 30 /PRNewswire/ -- Health systems should have bigger incentives and rewards for innovators - according to a panel of European healthcare experts. Healthcare systems are large,...

Supportive Care in Cancer: Palonosetron Recommended 5-HT3 Antagonist for Emesis Prevention by MASCC/ESMO
30th June 2009 LUGANO, Switzerland, June 30 /PRNewswire/ -- About Palonosetron (Aloxi(R), Onicit(R), Paloxi(R)) Palonosetron (palonosetron hydrochloride) is a selective 5-HT3 receptor antagonist, developed for...

Cellular Technology Extends the Boundaries of E-healthcare, Says Frost & Sullivan
30th June 2009 LONDON, June 30 /PRNewswire/ -- Wireless technologies has been of immense value to medical practitioners, enabling them to increase productivity and improve the availability of quality healthcare...

Frost & Sullivan Looks at Biometrics Advancement in Civil Security: Exploring Opportunities for Today and Beyond
30th June 2009 LONDON, June 30 /PRNewswire/ -- Governments across the globe are looking for new and sophisticated technologies to combat rising crime and terrorism. Recent advancements in biometric technology...

Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market, States Frost & Sullivan
30th June 2009 LONDON, June 30 /PRNewswire/ -- Two-dimensional electrophoresis (2DE) is the most cost-effective protein profiling technology and is the only technology in which the constituents of a protein sample...

New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF
30th June 2009 AMSTERDAM, The Netherlands, June 30 /PRNewswire/ -- New data from an economic analysis presented today at this year's European Society of Human Reproduction and Embryology (ESHRE) congress...

Camouflage Creams Insects Naturally
30th June 2009 LONDON, June 30 /PRNewswire/ -- At last a great smelling moisturiser to keep bugs at bay. Following on from the success of the incognito range of sprays, soaps and scrubs comes a 100% natural formula...

Elsevier Launches SciVal Spotlight: New Tool Provides Multidisciplinary View of Research Performance
29th June 2009 AMSTERDAM, June 29 /PRNewswire/ -- Elsevier, a world-leading publisher of scientific, technical and medical information products and services, today announced the launch of SciVal Spotlight, a...

Health Robotics Announces i.v.STATION(TM) Contract With Grifols in Spain, Portugal and South America
29th June 2009 BOZEN , Italy, June 29 /PRNewswire/ -- Health-Robotics today announced that it has signed an exclusive 5-year strategic partnership with Grifols S.A., the leading Pharmacy Automation provider in...

Elsevier Announces 2008 Journal Impact Factor Highlights
29th June 2009 AMSTERDAM, June 29 /PRNewswire/ -- Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced the highlights of its journal impact factor...

Hospital Information Systems (HIS) Markets in Europe: Frost & Sullivan Reveals the Cost, Crunch and the Care Value
29th June 2009 LONDON, June 29 /PRNewswire/ -- The Healthcare Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the European Hospital Information Systems (HIS)...

Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals
29th June 2009 UPPSALA, Sweden, June 29 /PRNewswire/ -- Gyros AB, the leading provider of automated micro-immunoassays for therapeutic protein development, announces that it has raised SEK 80 million (approximately...

Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
29th June 2009 SOUTHAMPTON, England, June 29 /PRNewswire/ -- Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, announces...

The Foundation for Research in Osteoporosis and Bone Disease (FROMO) Awards the 2009 Fellowship in Renal Physiology and Pathophysiology
29th June 2009 GENEVA, June 29 /PRNewswire/ -- The Foundation for Research in Osteoporosis and Bone Disease (FROMO) announced the recipients of the 2009 Fellowship in Renal Physiology and Pathophysiology: Andreas...

MEDRAD Multi Vendor Service Launches TotalRepair(SM) in Europe
29th June 2009 MAASTRICHT, Netherlands, June 29 /PRNewswire/ -- MEDRAD, INC., Multi Vendor Service has extended TotalRepair, the first and only guaranteed ultrasound probe repair solution, to European markets....

Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
29th June 2009 S. MAMEDE DO CORONADO, Portugal, June 29 /PRNewswire/ -- Data presented today, in Budapest, demonstrated that add-on treatment with the novel, once-daily anti-epileptic Zebinix(R)* (eslicarbazepine...

Kiwanis International Pursuing Second Worldwide Service Project
28th June 2009 NASHVILLE, Tennessee, June 28 /PRNewswire/ -- In 1994, Kiwanis International made a pledge to help protect children from the scourges of Iodine Deficiency Disorders in its first Worldwide Service...

Positive CHMP Opinion for JAVLOR(R) in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum-Containing Regimen
26th June 2009 CASTRES, France, June 26 /PRNewswire/ -- Laboratoires Pierre Fabre announce today that the Committee for Medicinal Products for Human Use (CHMP), the scientific advisory committee of the European...

Eisai Opens GBP100 Million European Headquarters Facility in the UK
26th June 2009 HATFIELD, England, June 26 /PRNewswire/ -- Eisai, one of the world's leading pharmaceutical companies, today officially opened its new 'European Knowledge Centre' (the EKC) in...

Clavis Pharma Raises NOK 129 Million (USD 20 Million) in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug Candidates
26th June 2009 OSLO, Norway, June 26 /PRNewswire/ -- Clavis Pharma ASA (OSE: CLAVIS) today announced that the Company has raised NOK 129 million (equivalent to USD 20 million) in gross proceeds through a private...

The Impact of Financing Mechanisms on Patient Access to Innovation - EHTI Presents Research Findings
26th June 2009 BRUSSELS and INNSBRUCK, Austria, June 26 /PRNewswire/ -- One of the questions the European Health Technology Institute for Socio-Economic Research (EHTI) hopes to answer is whether national...

Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer
26th June 2009 GENEVA, and REDWOOD CITY, California, June 26 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported that the St. Gallen International Consensus Panel on the Primary Therapy of Early...

LAP-BAND(TM) is First Obesity Intervention Device in Europe Indicated for Weight Loss That Improves or Leads to Remission of Type 2 Diabetes
26th June 2009 LONDON, June 26 /PRNewswire/ -- Allergan's LAP-BAND(TM) AP System for obesity intervention has become the first device to receive official European approval for weight loss that leads to improvement...

Torchmark Prices Senior Notes Offering
25th June 2009 MCKINNEY, Texas, June 25 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) announced today that it has priced an offering of US$300 million in aggregate principal amount of 9.25% Senior Notes that...

ONGLYZA(TM) (saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes
25th June 2009 PARIS and LONDON, June 25 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (LSE: AZN) today announced that their marketing authorisation application for...

Quotient Bioresearch Acquires Radiochemical Custom Synthesis Operations From GE Healthcare
25th June 2009 CAMBRIDGE, England, June 25 /PRNewswire/ --

Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide
25th June 2009 AMSTERDAM, June 25 /PRNewswire/ -- Elsevier, a world-leading publisher of scientific, technical and medical information products and services, today announced results of its SciVal Spotlight...